NCT06062706

Brief Summary

This will be a study to examine the outcomes of open, laparoscopic, and robotic Living Donor Liver Transplantation (LDLT) procedures. The analysis will encompass 3,448 cases (1,724 donor-recipient pairs) from January 2011 to March 2023, documenting the transition between these surgical techniques, with a noted crossover in 2018.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,448

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 6, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 12, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

October 2, 2023

Completed
13 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2023

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2023

Completed
Last Updated

October 2, 2023

Status Verified

September 1, 2023

Enrollment Period

2 months

First QC Date

September 12, 2023

Last Update Submit

September 28, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Donor overall morbidity rate

    Complication rate of any severity according to the Clavien-Dindo Classification

    From date of donor hepatectomy until the date of first hospital discharge assessed up to 90 days postoperatively.

  • Recipient overall morbidity rate

    Complication rate of any severity according to the Clavien-Dindo Classification

    From date of liver transplantation until the date of hospital discharge assessed up to 90 days postoperatively.

  • Recipient in-hospital mortality rate

    Recipient death up to 90 days of follow up

    From date of liver transplantation until the date of death assessed up to 90 days post-transplant.

Secondary Outcomes (6)

  • Donor minimally invasive surgery conversion to open rate

    Time from operation start until conversion to open in minutes assessed up to 720 min

  • Donor hospital stay in days

    From date of donor hepatectomy until the date of first hospital discharge assessed up to 90 days postoperatively.

  • Recipient Intensive Care Unit (ICU) stay in days

    Total number of days hospitalised in ICU, from date of liver transplant until the date of discharge from ICU assessed up to 90 days postoperatively.

  • Recipient hospital stay in days

    From date of liver transplant until the date of first hospital discharge assessed up to 90 days postoperatively.

  • Graft survival rates

    From date of liver transplantation until the date of re-transplantation or recipient death or last follow up assessed up to 120 months post-transplant

  • +1 more secondary outcomes

Other Outcomes (2)

  • Major morbidity rates

    From date of operation until the date of hospital discharge assessed up to 90 days postoperatively.

  • Specific complication rates

    From date of operation until the date of hospital discharge assessed up to 90 days postoperatively.

Study Arms (3)

Open

Open donor hepatectomy approach: a portion of the liver is resected from a living donor using the traditional open surgical technique, involving a large incision to access the liver directly. This method is most commonly used in living donor liver transplantation nowadays.

Procedure: Donor hepatectomy

Laparoscopic

Laparoscopic donor hepatectomy is a minimally invasive surgical approach where a portion of the liver is resected from a living donor using small incisions and specialized instruments.

Procedure: Donor hepatectomy

Robotic

Robotic donor hepatectomy is an advanced, minimally invasive surgical technique where a portion of the liver is resected from a living donor using robotic instruments. This method is known to provide enhanced precision, improved ergonomics, and superior 3D visualization.

Procedure: Donor hepatectomy

Interventions

Donor hepatectomy is a surgical procedure to resect a portion of the liver from a living donor for transplantation. This usually involved the right lobe, the left lobe or the left lateral section of the liver. Depending on the surgical method, this can be achieved through open, laparoscopic, or robotic-assisted techniques. As for the recipient, liver transplantation involves a total hepatectomy of the diseased liver from the recipient and implantation of the liver graft from the donor. This is typically performed using the open surgical approach.

Also known as: Recipient liver transplantation
LaparoscopicOpenRobotic

Eligibility Criteria

Age1 Month - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study cohort consists of 1,724 living donor and recipient pairs, amounting to a total of 3,448 individuals. These donors and recipients participated in living donor liver transplantation (LDLT) procedures at the King Faisal Specialist Hospital and Research Center in Riyadh, Saudi Arabia. The donors provided a portion of their liver for transplantation. The recipient group is diverse, including both adult and pediatric patients receiving transplants from adult donors. Both laparoscopic-assisted and robotic-assisted transplant procedures will be part of the study to ensure an intention-to-treat analysis.

You may qualify if:

  • All donor and recipient pairs that underwent LDLT at the study institution
  • Between 01 January 2011 to 31 March 2023
  • Both adult-to-adult and adult-to-pediatric LDLT are included.

You may not qualify if:

  • Dual and domino LDLT are excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Organ Transplant Center of Excellence, King Faisal Specialist Hospital & Research Centre

Riyadh, 11563, Saudi Arabia

Location

MeSH Terms

Conditions

End Stage Liver DiseaseLiver Failure, AcuteAcute-On-Chronic Liver FailureCarcinoma, Hepatocellular

Condition Hierarchy (Ancestors)

Liver FailureHepatic InsufficiencyLiver DiseasesDigestive System DiseasesAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsLiver NeoplasmsDigestive System NeoplasmsNeoplasms by Site

Study Officials

  • Dieter C Broering, MD, PhD

    Organ Transplant Center of Excellence, King Faisal Specialist Hospital & Research Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 12, 2023

First Posted

October 2, 2023

Study Start

August 6, 2023

Primary Completion

October 15, 2023

Study Completion

October 30, 2023

Last Updated

October 2, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations